 <h1>Nafarelin Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to nafarelin: nasal spray</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, nafarelin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking nafarelin:</p><p>
<i>More common</i>
</p><p>
<i>For adults (female)</i>
</p><ul>
<li>Breast enlargement</li>
<li>light vaginal bleeding between regular menstrual periods, called spotting</li>
<li>longer or heavier menstrual periods</li>
<li>vaginal bleeding between regular menstrual periods, called breakthrough bleeding</li>
</ul><p>
<i>For children (male)</i>
</p><ul>
<li>Body odor</li>
<li>growth of pubic hair</li>
</ul><p>
<i>For children (female)</i>
</p><ul>
<li>Body odor</li>
<li>breast enlargement</li>
<li>growth of pubic hair</li>
<li>light vaginal bleeding between regular menstrual periods, called spotting</li>
<li>longer or heavier menstrual periods</li>
<li>vaginal bleeding between regular menstrual periods, called breakthrough bleeding</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Chest pain</li>
<li>rash, hives or welts, itching</li>
<li>redness of the skin</li>
</ul><p>
<i>Less common or rare</i>
</p><p>
<i>For adults (female)</i>
</p><ul>
<li>Fast or irregular heartbeat</li>
<li>numbness or tingling of the hands or feet</li>
<li>pain in the eyes or joints</li>
<li>patchy brown or dark brown discoloration of the skin</li>
<li>pelvic bloating or tenderness</li>
<li>unexpected or excess milk flow from the breasts</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><p>
<i>For adults (female)</i>
</p><ul>
<li>Cough</li>
<li>difficulty with speaking</li>
<li>dizziness or lightheadedness</li>
<li>double vision</li>
<li>fainting</li>
<li>fast heartbeat</li>
<li>inability to move the arms, legs, or facial muscles</li>
<li>inability to speak</li>
<li>nausea</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>pain, redness, or swelling in the arm or leg</li>
<li>slow speech</li>
<li>sweating</li>
<li>troubled breathing</li>
<li>vomiting</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Incidence not known </i>
</p><ul>
<li>Anxiety or mental depression</li>
<li>changes in vision</li>
<li>cold, clammy, or pale skin</li>
<li>confusion</li>
<li>convulsions</li>
<li>headache</li>
<li>irregular heartbeats</li>
<li>nightmares or unusually vivid dreams</li>
<li>slow heart rate</li>
<li>vomiting</li>
<li>weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of nafarelin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><p>
<i>For adults (female)</i>
</p><ul>
<li>Acne</li>
<li>dandruff</li>
<li>hot flashes</li>
<li>increase or decrease in sexual desire</li>
<li>increased hair growth, often abnormally distributed</li>
<li>mood swings</li>
<li>muscle pain</li>
<li>oily skin</li>
<li>pain during sexual intercourse</li>
<li>rapid weight gain</li>
<li>reduced breast size</li>
<li>stopping of menstrual periods</li>
<li>swelling of the feet or lower legs</li>
<li>vaginal dryness</li>
</ul><p>
<i>For children (male)</i>
</p><ul>
<li>Acne</li>
<li>dandruff</li>
<li>mood swings</li>
<li>oily skin</li>
</ul><p>
<i>For children (female)</i>
</p><ul>
<li>Acne</li>
<li>dandruff</li>
<li>hot flashes</li>
<li>mood swings</li>
<li>oily skin</li>
</ul><p>
<i>Less common or rare</i>
</p><p>
<i>For adults (female)</i>
</p><ul>
<li>Breast pain</li>
<li>headache (mild and transient)</li>
<li>irritated or runny nose</li>
<li>mental depression (mild and transient)</li>
</ul><p>
<i>For children (male)</i>
</p><ul>
<li>Irritated or runny nose</li>
</ul><p>
<i>For children (female)</i>
</p><ul>
<li>Irritated or runny nose</li>
<li>white or brownish vaginal discharge</li>
</ul><p>
<!-- end nasal spray --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nafarelin: nasal spray</i></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hot flashes/hot flush (up to 90%)</p>
<p><b>Common</b> (1% to 10%): Chest pain, edema, hyper/hypotension</p>
<p><b>Frequency not reported</b>: Palpitations</p>
<p><b>Postmarketing reports</b>: Arterial thromboembolism, deep vein thrombosis, myocardial infarction, venous thromboembolism<sup>[Ref]</sup></p><p>Hot flashes occurred commonly in adult women who were treated for endometriosis.  Approximately 3% of children developed transient hot flashes.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Decreased libido (up to 23%), emotional/affect lability (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Depression, increased libido, insomnia</p>
<p><b>Postmarketing reports</b>: Aggression, anger, impatience, irritability, suicidal ideation, suicide attempt<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Vaginal dryness (up to 19%)</p>
<p><b>Common</b> (1% to 10%): Transient breast enlargement, breast atrophy/decreased breast size, vulvovaginal dryness, artificial menopause, uterine hemorrhage, vaginal bleeding, white/brown vaginal discharge</p>
<p><b>Uncommon</b> (0.1% to 1%): Ovarian cyst</p>
<p><b>Frequency not reported</b>: Ovarian hyperstimulation syndrome<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 18%)</p>
<p><b>Common</b> (1% to 10%): Paresthesia</p>
<p><b>Frequency not reported</b>: Migraines</p>
<p><b>Postmarketing reports</b>: Convulsions, stroke, transient ischemic attack<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Acne (up to 14%)</p>
<p><b>Common</b> (1% to 10%): Transient increase in pubic hair, body odor, seborrhea, pruritus, rash, urticaria, hirsutism</p>
<p><b>Uncommon</b> (0.1% to 1%): Alopecia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Rhinitis, dyspnea, nasal irritation</p>
<p><b>Frequency not reported</b>: Shortness of breath</p>
<p><b>Postmarketing reports</b>: Interstitial pneumonitis, pulmonary embolism, pulmonary fibrosis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia, decreased bone mineral density</p>
<p><b>Uncommon</b> (0.1% to 1%): Arthralgia</p>
<p><b>Postmarketing reports</b>: Arthritic symptoms<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Estrogen deficiency</p>
<p><b>Frequency not reported</b>: Pituitary enlargement/asymmetry/pituitary gland changes (size and shape)</p>
<p><b>Postmarketing reports</b>: Pituitary apoplexy<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Increased/decreased weight</p>
<p><b>Frequency not reported</b>: Increased serum alkaline phosphatase, increased total cholesterol/triglycerides<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Drug hypersensitivity<sup>[Ref]</sup></p><h3>Oncologic</h3><p>A patient with congenital adrenal hyperplasia developed an adrenal rest tumor 8 months after discontinuing treatment; however, correlation to treatment is unlikely.</p>
<p></p>
<p>Pituitary gland adenomas have been observed in a few children receiving treatment; however, the relationship to treatment is unknown.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Adrenal rest tumor of the testis, pituitary gland adenoma<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Increased AST/ALT, serious liver injury<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision<sup>[Ref]</sup></p><h3>Other</h3><p><b>Postmarketing reports</b>: Crying</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Synarel (nafarelin)." Roche Laboratories, Nutley, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_4">4. "Product Information. Synarel Nasel Solution (nafarelin nasal)." Searle, Chicago, IL. </p><p id="ref_5">5. "Product Information. Synarel (nafarelin nasal)." Pfizer U.S. Pharmaceuticals Group, New York, NY. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about nafarelin</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>En Español</li>
<li>7 Reviews</li>
<li>Drug class: gonadotropin releasing hormones</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nafarelin Nasal &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Synarel</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Endometriosis</li>
<li>Precocious Puberty</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nafarelin: nasal spray</i></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hot flashes/hot flush (up to 90%)</p><p><b>Common</b> (1% to 10%): Chest pain, edema, hyper/hypotension</p><p><b>Frequency not reported</b>: Palpitations</p><p><b>Postmarketing reports</b>: Arterial thromboembolism, deep vein thrombosis, myocardial infarction, venous thromboembolism<sup>[Ref]</sup></p><p>Hot flashes occurred commonly in adult women who were treated for endometriosis.  Approximately 3% of children developed transient hot flashes.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Decreased libido (up to 23%), emotional/affect lability (up to 15%)</p><p><b>Common</b> (1% to 10%): Depression, increased libido, insomnia</p><p><b>Postmarketing reports</b>: Aggression, anger, impatience, irritability, suicidal ideation, suicide attempt<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Vaginal dryness (up to 19%)</p><p><b>Common</b> (1% to 10%): Transient breast enlargement, breast atrophy/decreased breast size, vulvovaginal dryness, artificial menopause, uterine hemorrhage, vaginal bleeding, white/brown vaginal discharge</p><p><b>Uncommon</b> (0.1% to 1%): Ovarian cyst</p><p><b>Frequency not reported</b>: Ovarian hyperstimulation syndrome<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 18%)</p><p><b>Common</b> (1% to 10%): Paresthesia</p><p><b>Frequency not reported</b>: Migraines</p><p><b>Postmarketing reports</b>: Convulsions, stroke, transient ischemic attack<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Acne (up to 14%)</p><p><b>Common</b> (1% to 10%): Transient increase in pubic hair, body odor, seborrhea, pruritus, rash, urticaria, hirsutism</p><p><b>Uncommon</b> (0.1% to 1%): Alopecia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Rhinitis, dyspnea, nasal irritation</p><p><b>Frequency not reported</b>: Shortness of breath</p><p><b>Postmarketing reports</b>: Interstitial pneumonitis, pulmonary embolism, pulmonary fibrosis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia, decreased bone mineral density</p><p><b>Uncommon</b> (0.1% to 1%): Arthralgia</p><p><b>Postmarketing reports</b>: Arthritic symptoms<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Estrogen deficiency</p><p><b>Frequency not reported</b>: Pituitary enlargement/asymmetry/pituitary gland changes (size and shape)</p><p><b>Postmarketing reports</b>: Pituitary apoplexy<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Increased/decreased weight</p><p><b>Frequency not reported</b>: Increased serum alkaline phosphatase, increased total cholesterol/triglycerides<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Drug hypersensitivity<sup>[Ref]</sup></p><h3>Oncologic</h3><p>A patient with congenital adrenal hyperplasia developed an adrenal rest tumor 8 months after discontinuing treatment; however, correlation to treatment is unlikely.</p><p></p><p>Pituitary gland adenomas have been observed in a few children receiving treatment; however, the relationship to treatment is unknown.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Adrenal rest tumor of the testis, pituitary gland adenoma<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Increased AST/ALT, serious liver injury<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision<sup>[Ref]</sup></p><h3>Other</h3><p><b>Postmarketing reports</b>: Crying</p><p id="ref_1">1. "Product Information. Synarel (nafarelin)." Roche Laboratories, Nutley, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_4">4. "Product Information. Synarel Nasel Solution (nafarelin nasal)." Searle, Chicago, IL. </p><p id="ref_5">5. "Product Information. Synarel (nafarelin nasal)." Pfizer U.S. Pharmaceuticals Group, New York, NY. </p><h2>More about nafarelin</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>En Español</li>
<li>7 Reviews</li>
<li>Drug class: gonadotropin releasing hormones</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nafarelin Nasal &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Endometriosis</li>
<li>Precocious Puberty</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>